BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3577766)

  • 1. Monocyte chemotaxis: a method for routine in vitro investigation using lactic dehydrogenase as a marker enzyme.
    Mrowietz U; Ternowitz T
    Acta Pathol Microbiol Immunol Scand C; 1987 Feb; 95(1):1-7. PubMed ID: 3577766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rapid method for monocyte isolation and chemotaxis.
    Antrum RM; Solomkin JS
    J Clin Lab Immunol; 1986 Mar; 19(3):139-42. PubMed ID: 3712418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotaxis of purified human monocytes in vitro: lack of accessory cell requirement.
    Falk W; Leonard EJ
    Infect Immun; 1982 May; 36(2):591-7. PubMed ID: 7085073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human monocyte adherence: a primary effect of chemotactic factors on the monocyte to stimulate adherence to human endothelium.
    Doherty DE; Haslett C; Tonnesen MG; Henson PM
    J Immunol; 1987 Mar; 138(6):1762-71. PubMed ID: 3819394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human monocyte chemotaxis to complement-derived chemotaxins is enhanced by Gc-globulin.
    Piquette CA; Robinson-Hill R; Webster RO
    J Leukoc Biol; 1994 Mar; 55(3):349-54. PubMed ID: 8120452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement activation products and monocyte migratory function in trauma.
    Antrum RM; Solomkin JS
    Curr Surg; 1985; 42(4):301-3. PubMed ID: 3875452
    [No Abstract]   [Full Text] [Related]  

  • 7. Monocyte function in the acquired immune deficiency syndrome. Defective chemotaxis.
    Smith PD; Ohura K; Masur H; Lane HC; Fauci AS; Wahl SM
    J Clin Invest; 1984 Dec; 74(6):2121-8. PubMed ID: 6511917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monocyte dysfunction in severe trauma: evidence for the role of C5a in deactivation.
    Antrum RM; Solomkin JS
    Surgery; 1986 Jul; 100(1):29-37. PubMed ID: 3726758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of monocyte function by complement activation products.
    Antrum RM; Solomkin JS
    J Surg Res; 1985 May; 38(5):468-74. PubMed ID: 3990275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human monocyte and neutrophil chemotaxis in vitro employing 51Cr-labelled leukocytes.
    Ternowitz T
    Acta Pathol Microbiol Immunol Scand C; 1985 Oct; 93(5):189-93. PubMed ID: 4083015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil-endothelial cell interactions. Modulation of neutrophil adhesiveness induced by complement fragments C5a and C5a des arg and formyl-methionyl-leucyl-phenylalanine in vitro.
    Tonnesen MG; Smedly LA; Henson PM
    J Clin Invest; 1984 Nov; 74(5):1581-92. PubMed ID: 6501563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atopic dermatitis: influence of bacterial infections on human monocyte and neutrophil granulocyte functional activities.
    Mrowietz U; Konter U; Traut R; Schröder JM; Christophers E
    J Allergy Clin Immunol; 1988 Dec; 82(6):1027-36. PubMed ID: 2849616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of human monocyte chemoattractant binding by flow cytometry.
    Leonard EJ; Noer K; Skeel A
    J Leukoc Biol; 1985 Sep; 38(3):403-13. PubMed ID: 3861752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moderate inhibitory effect of interleukin-10 on human neutrophil and monocyte chemotaxis in vitro.
    Vicioso MA; Garaud JJ; Réglier-Poupet H; Lebeaut A; Gougerot-Pocidalo MA; Chollet-Martin S
    Eur Cytokine Netw; 1998 Sep; 9(3):247-53. PubMed ID: 9831173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monocyte and neutrophil chemotaxis in psoriasis. Relation to the clinical status and the type of psoriasis.
    Ternowitz T
    J Am Acad Dermatol; 1986 Dec; 15(6):1191-9. PubMed ID: 3027138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotaxis of radiolabeled equine neutrophils.
    Camp CJ; Leid RW
    Am J Vet Res; 1982 Mar; 43(3):397-401. PubMed ID: 7073055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of monocyte chemotactic function in inflammatory lesions. Role of inflammatory mediators.
    Katona IM; Ohura K; Allen JB; Wahl LM; Chenoweth DE; Wahl SM
    J Immunol; 1991 Jan; 146(2):708-14. PubMed ID: 1898961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of anti-C5a antibodies on human polymorphonuclear leukocyte function: chemotaxis, chemiluminescence, and lysosomal enzyme release.
    Hatherill JR; Stephens KE; Nagao K; Ishizaka A; Wilmarth L; Wang JC; Deinhart T; Larrick JW; Raffin TA
    J Biol Response Mod; 1989 Dec; 8(6):614-24. PubMed ID: 2600603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin chemotactic stimulation of HL-60 cells: studies on thrombin responsiveness as a function of differentiation.
    Bar-Shavit R; Hruska KA; Kahn AJ; Wilner GD
    J Cell Physiol; 1987 May; 131(2):255-61. PubMed ID: 3034923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of density changes and chemotactic receptors of leukocytes from chronic hemodialysis and peritoneal dialysis patients.
    Lewis SL; Van Epps DE; Chenoweth DE
    Blood Purif; 1987; 5(2-3):138-54. PubMed ID: 3040039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.